Igc Pharma Inc (IGC)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE Arca]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE Arca]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 03/31
| 06-2017 | 03-2017 | 12-2016 | 09-2016 | 06-2016 | |
| Sales | 53 | -120 | 250 | 162 | 289 |
| Cost of Goods | 7 | -52 | 122 | 91 | 202 |
| Gross Profit | 46 | -68 | 128 | 72 | 87 |
| Operating Expenses | 449 | 680 | 636 | 712 | 607 |
| Operating Income | -396 | -800 | -386 | -550 | -319 |
| Interest Expense | 0 | 0 | 47 | 51 | 43 |
| Other Income | -36 | -16 | 359 | 12 | 2 |
| Pre-tax Income | -433 | -816 | -74 | -589 | -360 |
| Net Income Continuous | -433 | -830 | -74 | -589 | -360 |
| Minority Interests | 0 | -42 | 38 | -5 | 23 |
| Net Income | $-432 | $-788 | $-112 | $-584 | $-384 |
| EPS Basic Total Ops | -0.02 | -0.03 | 0.00 | -0.02 | -0.02 |
| EPS Basic Continuous Ops | -0.02 | -0.03 | 0.00 | -0.02 | -0.02 |
| EPS Diluted Total Ops | -0.02 | -0.03 | 0.00 | -0.02 | -0.02 |
| EPS Diluted Continuous Ops | -0.02 | -0.03 | 0.00 | -0.02 | -0.02 |
| EBITDA(a) | $-390 | $-795 | $-190 | $-452 | $-221 |